Related Experiment Video
Updated: Jul 11, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Diabetes mellitus and heart failure].
M Füchtenbusch1, E Standl, W Otter
1Inst. für Diabetesforschung & Klinik für Endokrinologie, Diabetologie und Suchtmedizin, Krankenhaus Schwabing, München. Martin.Fuchtenbusch@gmx.de
MMW Fortschritte Der Medizin
|October 9, 2007
Summary
Patients with diabetes mellitus (DM) and chronic heart failure (CHF) face poor prognoses. Effective management requires standard CHF treatments, strict glucose control, and consideration of antidiabetic drug contraindications.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Context:
- Diabetes mellitus (DM) is a significant risk factor for chronic heart failure (CHF), affecting 10-15% of DM patients compared to 3% in non-DM individuals.
- Hyperglycemia and insulin resistance in DM are directly implicated in the pathogenesis of diastolic dysfunction and CHF.
- The co-occurrence of DM and CHF presents a complex clinical challenge with a poor prognosis.
Purpose:
- To outline the epidemiology, pathophysiology, diagnosis, and management of chronic heart failure (CHF) in patients with diabetes mellitus (DM).
- To emphasize the importance of integrated care addressing both glycemic control and cardiovascular management.
- To highlight specific considerations for antidiabetic medication use in CHF patients.
Summary:
- DM is an independent risk factor for CHF, with higher prevalence and poorer outcomes in affected patients.
- Diagnosis follows established guidelines, including ECG, natriuretic peptide testing, and echocardiography.
- Standard CHF pharmacotherapy (ACEIs, ARBs, BBs, diuretics, etc.) is indicated, alongside meticulous glucose control.
- Certain antidiabetic drugs (glitazones, metformin) have contraindications based on CHF severity (NYHA classes).
Impact:
- Improved understanding of the bidirectional relationship between DM and CHF.
- Guidance on diagnostic and therapeutic strategies for this high-risk patient population.
- Emphasis on personalized treatment considering both diabetes and heart failure status, including medication safety.
Related Concept Videos
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...